PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer

Yali Wang(Tongji Hospital), Yanmei Zou(Tongji Hospital)
Frontiers in Immunology
December 17, 2021
Cited by 38


Related Papers